Continuation of 08150 BSL4 Challenge Phase at TBRI
Principal Investigator(s)
Carrion, Ricardo
Collaborating Institutions
Battelle Memorial Institute
Funded by
Department of Defense
Research Start Date
Status
Inactive
The goal of this study is to investigate the immunogenicity and efficacy of Profectus BioSciences rVSVN4CT1-vectored trivalent (EBOV, SUDV and MARV) filovirus vaccine against an Intramuscular (IM) EBOV challenge in nonhuman primates (NHPs) when administered at various dose schedules. This supplement will only encompass report writing.